Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.

Literature DB >> 3592045

The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.

Abstract

Using the End-Stage Renal Disease Medical Information System and 1980 census information, the crude cumulative incidence among Blacks, Hispanics, and Whites in south central Los Angeles was determined to be 160.1, 49.28, and 55.3 per 100,000 respectively. Sex-specific rates were slightly greater in males. Among Blacks, nephrosclerosis and diabetes represented 41.5 and 30.2 per cent of the cases respectively and increased during the period 1980-85.

Entities: Disease

Mesh：

Year: 1987 PMID： 3592045 PMCID： PMC1647229 DOI： 10.2105/ajph.77.7.864

Source DB: PubMed Journal: Am J Public Health ISSN： 0090-0036 Impact factor: 9.308

6 in total

1. An areawide survey of treated end-stage renal disease.

Authors: J S Mausner; J K Clark; B I Coles; H Menduke
Journal: Am J Public Health Date: 1978-02 Impact factor: 9.308

2. Demographic analysis: end-stage renal disease and its treatment in the United States.

Authors: B T Burton; G H Hirschman
Journal: Clin Nephrol Date: 1979-02 Impact factor: 0.975

3. Race and end-stage renal disease.

Authors: A S Relman
Journal: N Engl J Med Date: 1982-05-27 Impact factor: 91.245

4. Racial differences in the incidence of treatment for end-stage renal disease.

Authors: S G Rostand; K A Kirk; E A Rutsky; B A Pate
Journal: N Engl J Med Date: 1982-05-27 Impact factor: 91.245

5. Racial factors in the incidence and causation of end-stage renal disease (ESRD).

Authors: R E Easterling
Journal: Trans Am Soc Artif Intern Organs Date: 1977

6. The incidence of treated end stage renal disease in the eastern United States: 1973-1979.

Authors: T Sugimoto; S J Rosansky
Journal: Am J Public Health Date: 1984-01 Impact factor: 9.308

6 in total

9 in total

1. Race and kidney disease: the scope of the problem.

Authors: Keith C Norris; Lawrence Y Agodoa
Journal: J Natl Med Assoc Date: 2002-08 Impact factor: 1.798

2. Association between circulating specific leukocyte types and incident chronic kidney disease: the Atherosclerosis Risk in Communities (ARIC) study.

Authors: Niu Tian; Alan D Penman; R Davis Manning; Michael F Flessner; Anthony R Mawson
Journal: J Am Soc Hypertens Date: 2011-11-03

The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.

1. An areawide survey of treated end-stage renal disease.

2. Demographic analysis: end-stage renal disease and its treatment in the United States.

3. Race and end-stage renal disease.

4. Racial differences in the incidence of treatment for end-stage renal disease.

5. Racial factors in the incidence and causation of end-stage renal disease (ESRD).

6. The incidence of treated end stage renal disease in the eastern United States: 1973-1979.

1. Race and kidney disease: the scope of the problem.

2. Association between circulating specific leukocyte types and incident chronic kidney disease: the Atherosclerosis Risk in Communities (ARIC) study.

Review 3. Treatment of hypertension in the presence of coexisting medical conditions.

Review 4. End-stage renal disease and race: an overview and perspective.

5. Renal failure among male Hispanics in the United States.

6. End state renal disease among Native Americans, 1983-86.

7. Evidence of selection as a cause for racial disparities in fibroproliferative disease.

8. End-stage renal disease in Taiwan: a case-control study.

Review 9. Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases.